Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Glucotrack, Inc. Director's Dealing 2025

Oct 8, 2025

35378_dirs_2025-10-07_bf7fada6-1273-47d0-9c0c-bed6e9462497.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Glucotrack, Inc. (GCTK)
CIK: 0001506983
Period of Report: 2025-03-25

Reporting Person: Balo Andrew K (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-25 Common Stock, par value $0.001 per share A 75 Acquired 75 Direct
2025-07-11 Common Stock, par value $0.001 per share A 3332 Acquired 3407 Direct
2025-10-03 Common Stock, par value $0.001 per share A 1285 Acquired 4692 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-10-03 Stock option (right to buy) $7.4 A 4055 Acquired 2035-10-03 Common Stock, par value $0.001 per share (4055) Direct

Footnotes

F1: Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date.